HBK Investments’s Pfizer PFE Stock Holding History

HBK Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9,400	Closed	-$345K	–	403
2023 Q2	$345K	Sell	9,400 -74,500	-89%	-$2.9M	﹤0.01%	347
2023 Q1	$3.42M	Buy	+83,900	New	+$3.62M	0.02%	118
2022 Q4	–	Sell	-70,200	Closed	-$3.07M	–	164
2022 Q3	$3.07M	Sell	70,200 -163,000	-70%	-$7.92M	0.02%	259
2022 Q2	$12.2M	Buy	233,200 +174,800	+299%	+$8.91M	0.07%	86
2022 Q1	$3.02M	Buy	+58,400	New	+$3.03M	0.01%	360
2021 Q3	–	Sell	-232,700	Closed	-$9.11M	–	858
2021 Q2	$9.11M	Buy	232,700 +159,400	+217%	+$6.2M	0.03%	135
2021 Q1	$2.66M	Buy	+73,300	New	+$2.6M	0.01%	423
2020 Q1	–	Sell	-93,806	Closed	-$3.49M	–	393
2019 Q4	$3.49M	Sell	93,806 -9,064	-9%	-$323K	0.03%	347
2019 Q3	$3.51M	Sell	102,870 -11,805	-10%	-$429K	0.04%	331
2019 Q2	$4.71M	Sell	114,675 -151,882	-57%	-$6.03M	0.04%	245
2019 Q1	$10.7M	Buy	+266,557	New	+$10.7M	0.11%	153

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

HBK Investments's PFE Position: Q1 2026 in Review

HBK Investments opened a new position in Pfizer (PFE) in Q1 2026: 10,878 shares worth $305K. The stake represents ﹤0.01% of the portfolio and ranks #309 among its holdings. This is a return to the name: HBK Investments previously reported a position in PFE as recently as Q1 2022.

HBK Investments first reported a position in PFE in Q4 2015 and has held it in 8 quarters since. The position peaked at $33.6M in Q1 2019. 2,946 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

HBK Investments held 10,878 shares of Pfizer worth $305K as of Q1 2026.
Pfizer was a new HBK Investments position in Q1 2026.
Pfizer made up ﹤0.01% of HBK Investments's portfolio in Q1 2026, its #309 holding.
HBK Investments first reported a position in Pfizer in Q4 2015 and has held it in 8 quarters since.
HBK Investments's Pfizer position peaked at $33.6M in Q1 2019.
2,946 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on HBK Investments's 13F filing for Q1 2026, filed 15 May 2026.